SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 305 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $91,303,694 | +4.1% | 753,205 | -1.7% | 0.03% | +7.1% |
| Q2 2023 | $87,744,411 | -15.0% | 766,193 | +2.3% | 0.03% | -17.6% |
| Q1 2023 | $103,268,654 | +33.2% | 749,246 | +25.2% | 0.03% | +25.9% |
| Q4 2022 | $77,555,000 | -9.5% | 598,498 | -22.8% | 0.03% | -15.6% |
| Q3 2022 | $85,704,000 | +64.3% | 775,333 | +10.6% | 0.03% | +77.8% |
| Q2 2022 | $52,172,000 | -32.1% | 700,760 | -28.7% | 0.02% | -21.7% |
| Q1 2022 | $76,789,000 | -22.3% | 982,874 | -10.4% | 0.02% | -14.8% |
| Q4 2021 | $98,786,000 | +12.8% | 1,097,043 | +16.3% | 0.03% | -3.6% |
| Q3 2021 | $87,554,000 | +0.9% | 943,449 | -15.4% | 0.03% | +3.7% |
| Q2 2021 | $86,741,000 | +2.1% | 1,115,790 | -2.1% | 0.03% | -3.6% |
| Q1 2021 | $84,985,000 | -68.8% | 1,140,293 | -28.6% | 0.03% | -71.1% |
| Q4 2020 | $272,401,000 | +25.4% | 1,597,331 | +3.2% | 0.10% | +10.2% |
| Q3 2020 | $217,268,000 | -10.4% | 1,547,142 | +2.3% | 0.09% | -15.4% |
| Q2 2020 | $242,390,000 | +54.2% | 1,511,747 | -5.9% | 0.10% | +25.3% |
| Q1 2020 | $157,171,000 | -13.1% | 1,606,770 | +14.7% | 0.08% | +10.7% |
| Q4 2019 | $180,830,000 | +131.0% | 1,401,305 | +34.8% | 0.08% | +114.3% |
| Q3 2019 | $78,282,000 | -59.7% | 1,039,316 | -18.7% | 0.04% | -59.8% |
| Q2 2019 | $194,247,000 | +41.7% | 1,278,257 | +11.1% | 0.09% | +38.1% |
| Q1 2019 | $137,098,000 | +354.4% | 1,150,200 | +316.2% | 0.06% | +320.0% |
| Q4 2018 | $30,170,000 | -45.9% | 276,383 | -19.9% | 0.02% | -21.1% |
| Q3 2018 | $55,756,000 | +32.1% | 345,230 | +7.4% | 0.02% | 0.0% |
| Q2 2018 | $42,214,000 | -8.2% | 321,299 | -48.2% | 0.02% | -9.5% |
| Q1 2018 | $45,962,000 | +692.6% | 620,418 | +495.4% | 0.02% | +600.0% |
| Q4 2017 | $5,799,000 | +17.2% | 104,195 | -4.5% | 0.00% | +50.0% |
| Q3 2017 | $4,947,000 | +245.5% | 109,080 | +156.7% | 0.00% | +100.0% |
| Q2 2017 | $1,432,000 | +163.2% | 42,489 | +25.3% | 0.00% | – |
| Q1 2017 | $544,000 | +27.1% | 33,908 | +117.2% | 0.00% | – |
| Q4 2016 | $428,000 | -83.5% | 15,611 | -63.0% | 0.00% | -100.0% |
| Q3 2016 | $2,594,000 | +138.9% | 42,242 | -25.7% | 0.00% | 0.0% |
| Q2 2016 | $1,086,000 | -20.3% | 56,887 | -18.5% | 0.00% | 0.0% |
| Q1 2016 | $1,362,000 | -53.8% | 69,762 | -8.7% | 0.00% | -50.0% |
| Q4 2015 | $2,949,000 | -9.3% | 76,429 | -24.5% | 0.00% | 0.0% |
| Q3 2015 | $3,251,000 | +0.2% | 101,232 | -5.1% | 0.00% | 0.0% |
| Q2 2015 | $3,245,000 | +943.4% | 106,627 | +356.4% | 0.00% | – |
| Q1 2015 | $311,000 | -26.8% | 23,365 | +15.9% | 0.00% | – |
| Q3 2014 | $425,000 | +5971.4% | 20,155 | +8857.8% | 0.00% | – |
| Q2 2014 | $7,000 | -41.7% | 225 | -56.7% | 0.00% | – |
| Q1 2014 | $12,000 | +500.0% | 520 | +447.4% | 0.00% | – |
| Q4 2013 | $2,000 | -99.9% | 95 | -99.8% | 0.00% | -100.0% |
| Q3 2013 | $2,280,000 | -74.9% | 48,263 | -79.7% | 0.00% | -83.3% |
| Q2 2013 | $9,070,000 | – | 238,298 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,315,000 | $170,397,700 | 13.20% |
| EcoR1 Capital, LLC | 2,999,453 | $388,669,120 | 11.83% |
| Evolutionary Tree Capital Management, LLC | 63,756 | $8,261,502 | 7.93% |
| Tri Locum Partners LP | 119,695 | $15,510,000 | 6.27% |
| Avoro Capital Advisors LLC | 3,175,000 | $411,416,500 | 6.15% |
| Camber Capital Management LP | 1,250,000 | $161,975 | 5.56% |
| Finepoint Capital LP | 131,457 | $17,034 | 5.51% |
| ACUTA CAPITAL PARTNERS, LLC | 67,500 | $8,746,650 | 5.38% |
| Logos Global Management LP | 220,000 | $28,507,600 | 3.34% |
| AFG FIDUCIARY SERVICES LIMITED PARTNERSHIP | 33,454 | $3,401,657 | 3.20% |